Provide transparent
information quickly
by Genexine
Accurate and fast delivery of key events and news of growing Genexine
Monthly News about Genexine
1 
Press Release
-
Sep 09, 2022Genexine’s First-in-Class Therapeutic DNA Vaccine Shows Significant Potential to Extend Survival in Late-Stage Cervica..더보기
-
Aug 25, 2022Genexine selected for Late-Breaking Oral Presentation of Phase 2 Study of GX-188E in Combination with KEYTRUDA® (pembro..더보기
-
Aug 17, 2022Genexine Announces Dosing of First Patient in Phase 2 clinical trial with Triple Combination Therapy in Patients with He..더보기
-
Jun 14, 2022Genexine Announces Completion of Enrollment in Phase 3 Clinical Trial with Its Proprietary Long-acting Growth Hormone, G..더보기
-
Jun 07, 2022Genexine reports encouraging top-line results of the Phase 1b/2 clinical trial with GX-I7 (efineptakin alfa) in refracto..더보기
Video
presented by CEO, Dr. Jungwon Woo.
1 Event Calendar
| Date | Event Details |
|---|
Awards and Recognitions
-
2020Sincere tax office in Gyeonggi-do
-
2019Certification of the Excellent Laboratory for Safety Management
-
2018The Appreciation Plaque by Korea Support Committe for IVI
-
2017Excellence Brain Capability Company (K-BrainPower)
-
2017Innovative Pharmaceutical Company
Copyrightⓒ 2020 Genexine, Inc. All rights reserved.
